Why Did the "Five-Year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists" Differ From Previous Randomized Controlled Study?

J Arthroplasty. 2024 Dec;39(12):e68-e69. doi: 10.1016/j.arth.2024.08.035.
No abstract available

Publication types

  • Letter